Corticosteroid-refractory Chronic Graft vs. Host Disease
1 clinical trials · Condition
◉ Watch Corticosteroid-refractory Chronic Graft vs. Host Disease
| Record | Firm | Date |
|---|---|---|
| Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease (NCT06824103) | Novartis Pharmaceuticals | 2025-09-09 |
Track Corticosteroid-refractory Chronic Graft vs. Host Disease automatically
Every clearance here is in the API, with alerts when new ones post.